Tags Posts tagged with "best marijuana stock"

best marijuana stock

0 1000

PotNetwork Holding, Inc. (POTN) Enters Partnership with Lawrence Taylor, Legendary NFL Football Star

PotNetwork Holding, Inc. (OTC Pink: POTN) (“Company”) is excited to announce that the Company has entered into a Joint Venture with Lawrence Taylor for the development and launch of the “LT Master Pain” Premium Line of CBD oils, a premium quality selection of products, designed to bring athletes and consumers a beneficial supplement to aid in pain relief, neurological support, and overall well-being.


Click Here Now To Read (POTN) Release


 

The Height of Marijuana Investing

In 2016, sales of marijuana and marijuana related products surged to almost $7 billion. If that seems like a lot, it’s only just beginning. At this point, almost 30 states have some sort of legalization or decriminalization which shouldn’t be surprising regardless of your views. The continuation of this process is inevitable. As states see not only the progress but the profit from taxes that states such as California are making, all states will push for legalization of the green plant.


Click Here Now To Read Full Article


Conservatives Move Towards Cannabis Investing

Cannabis is often thought to be a cause backed by only the most liberal, left-wing participants. Recently, dozens of high-profile conservatives have outwardly supported the decriminalization as well as the legalization of cannabis.


Click Here Now To Read Full Article


 

Marijuana Stocks Re-Initiates Coverage On Potnetwork Holdings Inc. (POTN)

PotNetwork Holding, Inc. (POTN) has been a major beneficiary of the legal cannabis movement and could be positioned to
see growth accelerate from here.


Click Here Now To Read Full Report


0 458
Marijuana Stocks Analyst_Coverage

When it comes to marijuana stocks, we think investors are rarely presented with the opportunity to get in on the ground on floor of an industry poised to see incremental revenue growth for decades to come. The last time investors had this opportunity was during the tech boom, which created countless millionaires.

We expect to see this happen again as the legal cannabis industry continues to be the fastest growing industry in the world and it is not even in the first inning of what will be a multi-decade growth cycle.

Access Our Full Report On PotNetwork Holdings Inc. (POTN) Below:

Marijuana Stocks POTN Potnetwork HoldingsMarijuana Stocks POTN Report


Pursuant to an agreement between MAPH and Potnetwork Holdings, Inc., we were hired for a period of 1 month from 6/1/2017 – 7/1/2017 to publicly disseminate information about (POTN) including on the Website and other media including Facebook and Twitter. We are being paid $21,000 (CASH) by Potnetwork Holdings, Inc. via First Capital Ventures, Inc. an affiliate company for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (POTN) which we purchased in the open market.We may buy or sell additional shares of (POTN) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 2877
Marijuana-Stocks-Nevada cannabis

The opening of Nevada’s recreational marijuana market has been a catalyst to many companies, however, some have benefited more than others.

Some of the biggest beneficiaries have been the vertically integrated companies as well as the holding companies.

One company that has benefited the most is mCig Inc. (MCIG). The company is levered to several legal cannabis markets and it has benefited from its unique and significant exposure to the Nevada market.

Posts Record Revenues and Enters New Markets

Today, mCig provided its shareholders with the latest project updates for Grow Contractors (its construction and consulting division), as well as its cannabis supply division after it entered the California cannabis market and posted record sales.

mCig said Grow Contractors will shatter its previous record revenue numbers after it took on cultivation management contracts and delivered on its plan for cultivation and production ownership while it mitigated risks through its consulting services. The company said the boom in Nevada will has led to an influx of requests for work. Some updates to mCig’s Grow Contractors division are as follows:

Nevada Projects:
• The $3.5 million, 330,000 square feet cultivation and extraction project known as Solaris will be Nevada’s largest cannabis facility. With all the required approvals in place, Solaris has been focused on construction.

• GWGA (formerly Sin City) was completed by Grow Contractors before the recreational deadline in Las Vegas. Although it is a relatively small facility (6,500 square feet), they have fully optimized the facility with vertical growing technologies to produce as much product as a 10,000 square foot facility.

• Acres Greenhouses: Following a signed contract and design phase approvals, Grow Contractors began work on 40,000 square foot of Greenhouses for Acres Farms in Amargosa, Nevada. Prior to the working relationship, Acres had existing greenhouses which were partially built and about 15% complete. The company will complete the greenhouse project soon.

Oregon Project:
• Located in a premier Oregon location 20 minutes from Portland, its $1.6 million, 115,000 square foot cultivation project is 90% complete. The facility has the latest lighting technology and is the first United States facility to use advanced DE HPS lighting by DEva Revolution. The two on-site licenses are operated by two master growers and the facility can produce 500 pound harvests on a monthly basis.

• Grow Contractors has many potential growth opportunities in the Oregon marijuana market and its current project slated to be completed by the end of July. The company is in discussions with a client to discuss a management relationship, expansion plans driving additional construction projects, and a potential joint venture.

Cannabis Supply Update
• Cannabiz Supply has become the go to supplier of packaging, accessories, and branding solutions for Nevada’s legal cannabis market. Increasing customer demand has allowed the company to increase its sales team, inventory, and move to a larger warehouse.

• Cannabiz Supply has started to expand its services with a new California sales office that will accommodate the hiring of additional team members and sales reps. A new rebranded website is expected to launch at the end of the month.

An Execution Story

We are favorable on this update and expect to see a favorable reaction from the market. Shares of mCig have come off its recent lows and we expect to see the company continued to report strong growth.

With leverage to massive marijuana markets like California, Nevada and Oregon, we are favorable on mCig’s long-term leverage and believe this is a company that investors need to watch.

0 1468
 

InCaseYouMissedIt: What To Know When Investing In Marijuana Stocks

 

Legal Marijuana is the fastest growing industry in the United States. In 2016, cannabis sales in North America went up 30% from 2015 to reach $6.7 billion.

Here’s a look at 7 fundamental tips that will help you understand the basics to invest in marijuana stocks:

 

 


Click Here Now To Read Full Article


 

Investing in Marijuana Stocks?

 

 

When it comes to investing in medical marijuana, whether or not to trust in this new market becomes the largest issue among investors. Because of the emerging industries history and connotations, many investors are put off despite the massive potential within the medical marijuana industry. For many years, plant has been associated with illegal ties and stigma’s that lead to misinformation about its benefits.

Now that the plant is legal in more than half of the country, the US as a whole has become more accepting of the plants possibilities.

Are Marijuana Stocks In Your Best Interest ?

 

 


Click Here Now To Read Full Article


 

 

 

Will Marijuana Stocks Be An Issue For Jeff Sessions ?

Marijuana stocks along with the rapidly growing legal marijuana industry has been nearly unstoppable for quite some time. The sales of legal medical and recreational marijuana are expected to expand by about 30% in 2017, 45% in 2018, and peak at just north of $17 billion in 2021, per the “Marijuana Business Factbook 2017,” a newly released report from Marijuana Business Daily. And this growth has meant one thing to businesses and investors: More money.

 


Click Here Now To Read Full Article


0 1285
marijuana_glaucoma
 

PotNetwork Holding, Inc. (POTN) Executes Diversification Strategy to Expand Position into the Cannabis Sector

PotNetwork Holding, Inc. ( OTC : POTN ), (“Company”) is very pleased to announce the reacquisition of PotNetwork.com, an online resource originally designed to become a leading industry specific news and content provider for the cannabis marketplace.


Click Here Now To Read (POTN) Release


Marijuana Stocks The Good The Bad The Ugly For Biotech

Although the biotech industry is poised to be one of the greatest beneficiaries of the legal cannabis movement, investors must be cautious with many of the companies focused on this opportunity. While opportunity is vast, it is also expensive and many of these companies do not have the capital needed to execute on its strategy. We have highlighted three biotech cannabis firms below in order of favorability and will continue to monitor how they execute on their plan from here.


Click Here Now To Read Full Article


 

 

Will These Marijuana Stocks Be The Future Of The Industry

Unless you’ve been hiding under a rock somewhere, you’re probably aware that the marijuana industry is booming. With more than half the U.S. legalizing medical marijuana, several legalizing recreational marijuana, and Canada recently making recreational marijuana legal nationwide, demand is greater than ever. Promising marijuana-based drugs could be on the market in the near future.


Click Here Now To Read Full Article


0 3805
marijuana stock

Among the many segments of the marijuana industry that marijuana stock traders pay attention to, CBD or cannabidiol has taken on a major role. This is not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market is projected t to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that has been attracting the attention of marijuana investors has been Potnetwork Holdings, Inc. (POTN).  Now don’t let the name fool you, this company, through its subsidiary First Capital Venture Co., owns Diamond CBD Inc.;

Over the last few months, POTN has been breaking barriers with its CBD brand while also hitting major milestones for the better part of the first half of the year.  What could be best of all is that 2017 may already have the stage set for a record setting period in POTN’s company history.

Big Growth Already In Play?

In May of this year (2017) the company announced that it had realized first quarter figures that exceeded expectation by over $100,000, for a total of $1,858,347.48. They also established a merchandising pipeline of 7,000 authorized retail vendors through its distribution channels, which puts Diamond CBD at approximately 10,000 stores in the United States.

If this wasn’t enough, POTN further catapulted off of this first quarter momentum by recognizing over $2million from April to mid-May with a pace set to outshine the first quarter figure by a relatively large margin. Even assuming this rate of revenue generation and accounting for zero growth or contraction in revenues, POTN could be an $11million company by year’s end. Again this is assuming the company holds this course and does about $1million in revenue per month.

Let’s compare just by Revenue Figures Alone From Most Recent Annual Filings:

√ Medical Marijuana, Inc. 

$8.00m (Annual, 2016) Market Cap: $264.7M

√ Rocky Mountain High Brands, Inc.

$1.08m (Annual, 2016)   Market Cap: $ 53.4M

√ mCig, Inc.  

$4.5m (Annual, 2017)  Market Cap: $ 70.0M

√ Axim Biotechnologies, Inc.

$0.047m (Annual, 2016) Market Cap: $551.4M

Now look at these figures, the multiples are astronomical compared to their market caps:

  • mCig trades at roughly 15.5 times revenue
  • Medical Marijuana Inc. trades at nearly 33 times revenue
  • Rocky Mountain trades over 49.4 times revenue
  • Axim is trading at an astronomical 11,732 times revenue!

Now look at the same situation for Potnetwork. We can look at the 2016 annual for apples to apples comparison but the real story comes when you consider that Diamond CBD is now its subsidiary (which we’ll get into in a moment).

√ Potnetwork Holding, Inc.     

$1.03m    (Annual, 2016)   Market Cap: $38.2M

Even with last year being a slower year for the company, which could be attributed to the company’s future outlook and its uncertainty, Potnetwork had only traded at roughly 4 times revenue.

Now, let’s take into account the company’s last few months of announcements. By the figures given, it’s assumed that as of the end of May, Potnetwork revenue was in the ballpark of roughly $3.86m on a conservative estimate based on Q1 revenue and May revenues of over $1million: first quarter 2017 revenue of $1,858,347.48, “over $1 Million in April,” and “over $1Million for May.”

Price Target Given: $0.25

Being that this will be the first time that Diamond’s operations will be under the POTN flag, we can look at a brief snapshot of the company, at least from a first half standpoint of this year.

Even by just assuming that this company sees zero growth ahead and an outstanding share count of even 600m, at current prices of roughly $0.08, POTN would be a $48m market cap company with revenues of roughly $3.86m; only 12 times revenue.

But so far this year, a “zero growth” scenario has not been the case at all. In fact, based on recent announcements, growth for the company has been very pronounced so far. This is most likely a big reason why analysts are finding that the valuation for POTN is low right now. SeeThru Equity initiated coverage on Potnnetwork Holdings and recently gave a price target of $0.25. Meanwhile, the company continues to hit the convention circuit to build attention around the investment side of Potnetwork & Diamond CBD’s company as well as the actual product side of the business through countless tradeshow appearances.

And just recently the company announced that it has sold 80,000 Chill gummies since taking to the roadshow circuit. And currently POTN is “re stocking” over a two-week period to re-up its inventory of this brand.

The takeaway? In our opinion, compared to other presumed “industry leaders,” POTN is still trading at a fraction of the revenue multiple that these other companies are. Additionally, based on announcements, it doesn’t appear that the company, with Diamond CBD, is closing the doors and stopping its revenue growth anytime soon. This could be one of the more, if not the most undervalued CBD stocks in the market right now and the fundamentals show rapid growth projected along the way.

 “We are ecstatic with our results. We have learned to set our expectations high. As a result of the timing of CBD’s growing popularity and the quality of our products, our products are consistently met with reseller and consumer enthusiasm resulting in continuous escalating sales.”

-Maria Gomez, Regional Vice President of Sales for Diamond CBD, Inc.

The opportunity for taking advantage of the growth that CBD is beginning to see could be important to take into consideration.  Figures estimate that the CBD market will grow to a $2.1 billion market in sales by 2020. That’s a 700% increase from 2016.

Think about this for a moment: POTN is already growing and is expecting to continue this growth for the year, according to several announcements already made during the last few months…this is all going to happen during a time where the CBD industry as a whole is also anticipating significant growth.

Having already come off of a banner quarter, we think that preliminary guidance from the company would suggest that this is something to be paying close attention to during the second half of 2017.

 


Pursuant to an agreement between MAPH and Potnetwork Holdings, Inc., we were hired for a period of 1 month from 6/1/2017 – 7/1/2017 to publicly disseminate information about (POTN) including on the Website and other media including Facebook and Twitter. We are being paid $21,000 (CASH) by Potnetwork Holdings, Inc. via First Capital Ventures, Inc. an affiliate company for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (POTN) which we purchased in the open market.We may buy or sell additional shares of (POTN) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 3651
Marijuana-stocks-biotech

Marijuana stocks continue to trade volatile and Tetra Bio Pharma (TBP.CN) (TBPMF) has been one of the top performers recently. The shares rallied 22% last week and Tetra is well positioned to move significantly higher.

We recently highlighted Tetra Bio and want to provide an update on the company after last week’s move higher.

Continues to Strengthen Management Team

One of the major focuses of Tetra this year has been on its management team and earlier this month, the company added Dr. Bill Cheliak to its Board of Directors.

Dr. Cheliak is CEO of Panag Pharma, a Canadian based bio-tech company focused on the development of novel cannabinoid based formulations for the treatment of pain and inflammation. He has over 20 years of experience as an entrepreneur and brings extensive deal making experience to the company. Dr. Cheliak currently serves as a Director for Solarvest and is Vice Chair of the Government of Canada’s Networks Centers Excellence Standing Selection Committee and Chair of the NCE Monitoring Committee.

Earlier in May, Tetra Bio further strengthened its management team after it announced that Robert Bechard was appointed to the position of Vice President, Finance and Business Development.

A Focus on Cannabis Biotech Treatments

The addition of Dr. Bill Cheliak to the Board comes one-week after Tetra Bio signed a definitive agreement with Panag Pharma for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation.

Per the definitive agreement, Tetra will have exclusive access to sell the ocular and topical drug products in North America with right of first negotiation for outside U.S. and Canadian territories. In addition, Tetra has a right of first negotiation for future cannabinoid-based products.

Tetra will work in close collaboration with Panag’s team of experts to ensure a rapid and successful development leading to marketing authorization. Panag will continue work in the development of novel products for unmet medical need and Tetra will take the lead in commercializing these novel drug products.

Positioned to Execute

The signing of a definitive agreement follows the submission of a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for a pharmaceutical drug formulation to treat various forms of cancer and ocular disease

Tetra is focused on developing cannabinoid based pharmaceutical treatments for indications that are multi-billion-dollar opportunities and we think these steps have significantly improved the company’s position within the biotech sector. This is a stock to watch and one we suggest putting toward the top of your radar screens.


 

Disclaimer: Pursuant to an agreement between MAPH and Tetra Bio-Pharma, we were hired for a period of 90 days to publicly disseminate information about (TBPMF) including on the Website and other media including Facebook and Twitter. We are being paid $75,000 (CASH) for and were paid 250,000 restricted common shares of Tetra Bio-Pharma. We may buy or sell additional shares of (TBPMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

marijuana-stocks-canadian-cannabis-

The Canadian stock market was closed for Victoria Day yesterday and today, three marijuana stocks reported several significant developments. We have highlighted these developments below to help you focus on important trends sweeping the industry.

New Cannabis IPO to Raise $50+ Million

One of newest and most differentiated Canadian cannabis producers, Cannabis Wheaton (CBW.V: TSX Venture) (KWFLF) announced a $50 million private placement and engaged a syndicate of agents co-led by Eight Capital and Canaccord Genuity.

The firm is selling special warrants and convertible debenture units and will use the net proceeds for general corporate purposes, for the financing of its streaming partners pursuant its streaming agreements, and for general and administrative expenses.

Cannabis Wheaton is off to a great start after the company reported that MMCAP International Inc. SPC intends to subscribe for up to $20,000,000 of the offering. The offering is expected to occur on June 21st and the company granted the underwriters an over-allotment option which increases the offering to $57.5 million.

Cronos’ Breaks Ground on a Brand New 315,000 sq. ft. Facility

Today, Cronos Group’s (MJN.V: TSX Venture) (PRMCF) wholly-owned licensed producer, the Peace Naturals Project broke ground on a 315,000 sq. ft. expansion that includes a 286,000 sq. ft. production facility, a 28,000 sq. ft. greenhouse, and an additional 1,200 sq. ft. extraction lab.

Upon completion, the facility is expected to be the largest purpose-built indoor cannabis production facility in the world. The facility is expected to complete by November and fully operational by summer 2018. This expansion will bring Peace’s total estimated production capacity to 40,000 kg a year.

The facility is designed to GMP certification standards and will include:

  • An area for proprietary genetic breeding
  • Pharma lab for cannabinoid and terpene extraction, identification, and formulation
  • R&D space for analyzing metabolite enhancement and new lighting technologies
  • Tissue culture laboratory
  • Industrial-grade kitchen
  • Processing infrastructure that supports production from other facilities

Cronos is breaking ground on the greenhouse today and the facility will be used to collect data and implement advanced cultivation techniques that can be replicated at its other production facilities. The company’s extraction lab will augment capabilities in both purification and recombination of cannabinoid compounds to create innovative formulated products. The greenhouse and lab are expected by the end of the summer.

Aurora to Supply Resources to Support a Groundbreaking Legal Case

Today, the Canadians for Fair Access to Medical Marijuana (CFAMM) reported an investment by Aurora Cannabis (ACB.V) (ACBFF) that is of a different nature than its prior investments.

CFAMM announced that Aurora has committed financial and other resources to support Gordon Skinner’s defense in what might be a potentially precedent-setting medical cannabis insurance coverage case. CFAMM has been providing strategic support to Skinner and Aurora’s resources will ensure that Skinner can defend his case.

On January 30th, the Nova Scotia Human Rights Commission ruled that the Board of Trustees of the Canadian Elevator Industry Welfare Trust Fund committed discrimination by denying coverage for the medical cannabis Skinner uses to manage chronic pain and other conditions resulting from a work-related injury that left him permanently impaired. Following the decision, the Board of Trustees filed an appeal against Skinner and the Commission in the Nova Scotia Court of Appeal. The appeal has been set for October 2, 2017.

Founded in 2014, Canadians for Fair Access to Medical Marijuana (CFAMM) is a federal non-profit, patient-run organization dedicated to protecting and improving the rights of medical cannabis patients. CFAMM’s goal is to enable patients to obtain fair and safe access to medical cannabis with a special focus on affordability, including private and public insurance coverage.

We want to commend Aurora on its commitment to improving the cannabis industry and supporting patients in need. This decision may have a lasting impact on the sector and could change the landscape of the Canadian medical cannabis industry.

 


Disclaimer: Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

    0 1512
    marijuana stock

    Our coverage of Vitality Biopharma (VBIO) continues to be spot on as we saw yet another strong day on May 2, 2017. VBIO has now gained 36% since we re-initiated coverage on the company on April 20, 2017, at $1.93.

    We issued an update on May 1st when VBIO was up 25% at $2.42 telling subscribers to watch for a break through resistance at $2.50. And just one day later, VBIO plowed through resistance and ran to a high of $2.62 on the biggest volume day it’s had in over a month. Stay tuned for further updates on VBIO as momentum seems to be on our side. If VBIO continues to hold above this resistance level, we could have plenty more days like May 2nd just around the corner.

    marijuana stocks VBIO

    Vitality Biopharma Adds Key Clinical Advisors in Gastroenterology

    In addition to this, Vitality Biopharma released news this morning (5-3) and announced the appointments of Dr. Douglas A. Drossman and Dr. Mark Gerich as clinical advisors with expertise in gastroenterology and treatment of digestive disorders. “We’re very excited to work with Dr. Drossman and Dr. Gerich at this stage of our development, as we advance into clinical studies and towards applying cannabinoids for the treatment of a variety of gastrointestinal disorders,” said Robert Brooke, Chief Executive Officer of Vitality Biopharma.

    Read The Full Press Release Here


     

    Disclaimer: Pursuant to an agreement between MAPH and a non affiliate third party, we were previously hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We may buy or sell additional shares of (VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

    0 1755
    marijuana

    University Of Florida To Be Funded $2.5 Million For Medical Marijuana Research

     

    A proposal that would award $2.5 million for UF to study medical marijuana recently moved forward in the Florida House of Representatives. The proposal states that money from the General Revenue Fund will be used to fund UF’s study on the safety and efficiency of medical cannabis. The bill, which passed through the Health Care Appropriations Subcommittee, moved into the Appropriations Committee on Friday.


    Click Here Now To Read Full Article


     

    Proposal In Nevada Aims To Loosen Cannabis Regulations

    Senate Bill 329, introduced by Sen. Tick Segerblom, D-Las Vegas, would loosen some medical marijuana regulations, an idea Governor Brian Sandoval has stated his opposition to. Senate Bill 329 proposes a plethora of changes to how the state deals with cannabis. It would allow veterans to obtain a medical marijuana card, add PTSD to the list of conditions that qualify for those cards and even make it so cards do not need to be renewed. Medical cards now last 12 months in Nevada.


    Click Here Now To Read Full Article


    Lawmakers In West Virginia Look At Legalizing Industrial Hemp

     

    Recently, Legislature sent separate proposals to the floor pushing for the legalization of commercial hemp production in West Virginia. Often, hemp is associated with marijuana. However, the new legislation declares hemp’s industrial uses. The bills state as long as the crop stays below a 1% threshold of tetrahydrocannabinol, the psychoactive component of cannabis, it can be produced after receiving licensing from the Agriculture Commissioner.


    Click Here Now To Read Full Article


    Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

    We are your #1 source for all things Marijuana Stocks, Subscribe Below!

    Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
    Ad Placements